GB9215921D0 - Anti-inflammatory compounds - Google Patents
Anti-inflammatory compoundsInfo
- Publication number
- GB9215921D0 GB9215921D0 GB929215921A GB9215921A GB9215921D0 GB 9215921 D0 GB9215921 D0 GB 9215921D0 GB 929215921 A GB929215921 A GB 929215921A GB 9215921 A GB9215921 A GB 9215921A GB 9215921 D0 GB9215921 D0 GB 9215921D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- inflammatory compounds
- inflammatory
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000003110 anti-inflammatory effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/64—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups singly-bound to oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Nutrition Science (AREA)
- Communicable Diseases (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929215921A GB9215921D0 (en) | 1992-07-27 | 1992-07-27 | Anti-inflammatory compounds |
| MX9304503A MX9304503A (es) | 1992-07-27 | 1993-07-26 | Compuestos antiinflamatorios. |
| IL106472A IL106472A0 (en) | 1992-07-27 | 1993-07-26 | Hydroxamic acid derivatives,their preparation and pharmaceutical compositions containing them |
| TW082105933A TW246670B (enrdf_load_stackoverflow) | 1992-07-27 | 1993-07-26 | |
| ZA935378A ZA935378B (en) | 1992-07-27 | 1993-07-26 | Anti-inflammatory compounds |
| CA002141214A CA2141214A1 (en) | 1992-07-27 | 1993-07-27 | Hydroxamic acid derivatives and their use as anti-inflammatory compounds |
| EP93917925A EP0652864A1 (en) | 1992-07-27 | 1993-07-27 | Hydroxamic acid derivatives and their use as anti-inflammatory compounds |
| AU47170/93A AU672810B2 (en) | 1992-07-27 | 1993-07-27 | Hydroxamic acid derivatives and their use as anti-inflammatory compounds |
| PCT/GB1993/001585 WO1994002448A1 (en) | 1992-07-27 | 1993-07-27 | Hydroxamic acid derivatives and their use as anti-inflammatory compounds |
| JP6504325A JPH07509462A (ja) | 1992-07-27 | 1993-07-27 | ヒドロキサム酸誘導体および抗炎症化合物としてのこれらの使用 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929215921A GB9215921D0 (en) | 1992-07-27 | 1992-07-27 | Anti-inflammatory compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB9215921D0 true GB9215921D0 (en) | 1992-09-09 |
Family
ID=10719360
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB929215921A Pending GB9215921D0 (en) | 1992-07-27 | 1992-07-27 | Anti-inflammatory compounds |
Country Status (10)
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ274244A (en) * | 1993-11-26 | 1997-09-22 | Pfizer | Isoxazoline derivatives and medicaments |
| JPH09505081A (ja) * | 1994-03-09 | 1997-05-20 | ファイザー・インコーポレーテッド | ５−リポキシゲナーゼ阻害物質としてのイソキサゾリン化合物 |
| JP3322885B2 (ja) * | 1995-02-02 | 2002-09-09 | 日研化学株式会社 | Ｎ−ヒドロキシウレア誘導体 |
| PT880362E (pt) | 1996-02-13 | 2005-10-31 | Searle & Co | Composicoes compreendendo um inibidor do cicloxigenase tipo 2 e um antagonista do receptor do leucotrieno b4 |
| DE69715382T2 (de) | 1996-02-13 | 2003-04-30 | G.D. Searle & Co., Chicago | Arzneimittelkombinationen mit immunosuppressiven wirkungen welche cyclooxygenase-2 inhibitoren und leukotrien lta4 hydrase-inhibitoren enthalten |
| PT888127E (pt) | 1996-02-13 | 2002-05-31 | Searle & Co | Combinacoes tendo efeitos imunossupresores contendo inibidores de cilcooxigenase-2 e inibidores de 5-lipoxigenase |
| NZ333441A (en) * | 1996-06-25 | 1999-05-28 | Cephalon Inc | Use of k-252a derivatives for the treatment of peripheral or central nerve disorders, and cytokine overproduction |
| BR9810760A (pt) * | 1997-07-31 | 2001-11-27 | Abbott Lab | Inibidores de hidroxamato reverso demetaloproteinases de matriz |
| US6235786B1 (en) | 1997-08-06 | 2001-05-22 | Abbott Laboratories | Reverse hydroxamate inhibitors of matrix metalloproteinases |
| US6294573B1 (en) | 1997-08-06 | 2001-09-25 | Abbott Laboratories | Reverse hydroxamate inhibitors of matrix metalloproteinases |
| US6288261B1 (en) | 1998-12-18 | 2001-09-11 | Abbott Laboratories | Inhibitors of matrix metalloproteinases |
| WO2000044712A1 (en) * | 1999-01-27 | 2000-08-03 | Abbott Laboratories | N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases |
| SE0103325D0 (sv) | 2001-10-04 | 2001-10-04 | Astrazeneca Ab | Novel compounds |
| WO2009099174A1 (ja) | 2008-02-07 | 2009-08-13 | Kyorin Pharmaceutical Co., Ltd. | アミノアルコール誘導体を有効成分とする炎症性腸疾患の治療剤又は予防剤 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI89709C (fi) * | 1985-03-16 | 1993-11-10 | Wellcome Found | Foerfarande foer framstaellning av terapeutiskt anvaendbara arylderivat |
| PL154186B1 (en) * | 1987-07-15 | 1991-07-31 | Wellcome Found | Method for manufacturing arylic derivatives of the hydroxamic acid |
| ATE144247T1 (de) * | 1990-07-25 | 1996-11-15 | Abbott Lab | Acetylenderivate mit lipoxygenase inhibitorischer wirkung |
| JPH06256285A (ja) * | 1990-12-11 | 1994-09-13 | Pfizer Pharmaceut Co Ltd | ヒドロキサム酸誘導体およびその用途 |
-
1992
- 1992-07-27 GB GB929215921A patent/GB9215921D0/en active Pending
-
1993
- 1993-07-26 ZA ZA935378A patent/ZA935378B/xx unknown
- 1993-07-26 TW TW082105933A patent/TW246670B/zh active
- 1993-07-26 IL IL106472A patent/IL106472A0/xx unknown
- 1993-07-26 MX MX9304503A patent/MX9304503A/es unknown
- 1993-07-27 WO PCT/GB1993/001585 patent/WO1994002448A1/en not_active Application Discontinuation
- 1993-07-27 EP EP93917925A patent/EP0652864A1/en not_active Withdrawn
- 1993-07-27 CA CA002141214A patent/CA2141214A1/en not_active Abandoned
- 1993-07-27 JP JP6504325A patent/JPH07509462A/ja active Pending
- 1993-07-27 AU AU47170/93A patent/AU672810B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO1994002448A1 (en) | 1994-02-03 |
| CA2141214A1 (en) | 1994-02-03 |
| ZA935378B (en) | 1995-01-26 |
| EP0652864A1 (en) | 1995-05-17 |
| TW246670B (enrdf_load_stackoverflow) | 1995-05-01 |
| MX9304503A (es) | 1994-04-29 |
| JPH07509462A (ja) | 1995-10-19 |
| AU4717093A (en) | 1994-02-14 |
| IL106472A0 (en) | 1993-11-15 |
| AU672810B2 (en) | 1996-10-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP9300508A0 (en) | Compounds | |
| GB9200245D0 (en) | Compounds | |
| GB9201755D0 (en) | Compounds | |
| GB9200210D0 (en) | Compounds | |
| GB9201694D0 (en) | Compounds | |
| GB9201693D0 (en) | Compounds | |
| GB9215921D0 (en) | Anti-inflammatory compounds | |
| GB9200566D0 (en) | Compounds | |
| GB9201751D0 (en) | Compounds | |
| GB9202792D0 (en) | Compounds | |
| GB9201692D0 (en) | Compounds | |
| GB9308652D0 (en) | Anti-inflammatory compounds | |
| GB9205859D0 (en) | Compounds | |
| GB9203512D0 (en) | Anti-inflammatory compounds | |
| GB9216682D0 (en) | Anti-inflammatory compounds | |
| GB9223161D0 (en) | Anti-inflammatory compounds | |
| GB9318432D0 (en) | Anti-inflammatory compounds | |
| GB9119554D0 (en) | Anti-inflammatory compounds | |
| GB9203919D0 (en) | Pharmaceutical anti-inflammatory compounds | |
| GB9219131D0 (en) | Compounds | |
| GB9205562D0 (en) | Compounds | |
| GB9203177D0 (en) | Compounds | |
| GB9203176D0 (en) | Compounds | |
| GB9203175D0 (en) | Compounds | |
| GB9203174D0 (en) | Compounds |